Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.
Kim H, Son N, Jeong D, Yoo M, Choi IY, Choi W, Chung YW, Ko SW, Byun S, Im S, Sim DW, Seo J, Kang MG, Lee JK, Seo YG, An HJ, Kim Y, Chae S, Jun DW, Chang DJ, Kim SG, Yi S, Yang HJ, Lee I, Park HJ, Lee JH, Kim B, Lee EE. Kim H, et al. Among authors: sim dw. Drug Saf. 2024 Mar 21. doi: 10.1007/s40264-024-01418-4. Online ahead of print. Drug Saf. 2024. PMID: 38512445
Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea.
Choe S, Lee S, Park CH, Lee JH, Kim HJ, Byeon SJ, Choi JH, Yang HJ, Sim DW, Cho BJ, Koo H, Kang MG, Jeong JB, Choi IY, Kim SH, Kim WJ, Jung JW, Lhee SH, Ko YJ, Park HK, Kang DY, Kim JH. Choe S, et al. Among authors: sim dw. Drug Saf. 2023 Jul;46(7):647-660. doi: 10.1007/s40264-023-01296-2. Epub 2023 May 27. Drug Saf. 2023. PMID: 37243963
Variation of clinical manifestations according to culprit drugs in DRESS syndrome.
Sim DW, Yu JE, Jeong J, Jung JW, Kang HR, Kang DY, Ye YM, Jee YK, Kim S, Park JW, Kang MG, Kim SH, Park HK, Yang MS, Hur GY, Lee JK, Choi JH, Kwon YE, Koh YI; Korean Severe Cutaneous Adverse Reactions Consortium. Sim DW, et al. Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):840-848. doi: 10.1002/pds.4774. Epub 2019 May 1. Pharmacoepidemiol Drug Saf. 2019. PMID: 31044478
A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY, Yun J, Lee SY, Koh YI, Sim DW, Kim S, Nam YH, Park JW, Kim SH, Ye YM, Park HK, Kim MH, Jee YK, Jung JW, Yang MS, Kim SH, Lee JK, Kim CW, Hur GY, Kim MY, Park SJ, Kwon YE, Choi JH, Kim JH, Kim SH, La HO, Kang MG, Park CS, Lee SM, Jeong YY, Kim HK, Jin HJ, Jeong JW, Lee J, Lee YW, Lee SE, Kim MS, Kang HR; Korean Severe Cutaneous Adverse Reactions Consortium. Kang DY, et al. Among authors: sim dw. J Allergy Clin Immunol Pract. 2021 Feb;9(2):929-936.e7. doi: 10.1016/j.jaip.2020.09.011. Epub 2020 Sep 19. J Allergy Clin Immunol Pract. 2021. PMID: 32961314
74 results